Sophia Lavigne

🚀 Innovant dans la biotech 🌿

[Prof Kausik Ray FMedSci @ProfKausikRay]

Our study. PCI pts in https://t.co/BIRdEyKQFC dichotomised by achieved ldl-c and LPa . Guidelines recommended ldl-c <55mg/dl attenuated risk of MACE from higher LPa (current approach). Risk still persisted. Hence Tx for LPa needed. Threshold for risk is 30mg/dl in this population

[Ateeqa Mujeeb Ullah @UllahAteeqa]

📣Excited to share our recent article on the practical approach to gastric lesions; the background mucosa & new nomenclatures!

Deeply grateful to Dr. Elizabeth Montgomery for her incredible support, mentorship & guidance.

https://t.co/tXBJEMzcLl

@LizMontgomeryMD #PathX #GIPath

[Drug Discovery World @DDWJournal]

Trial shows significant improvements in early Parkinson’s disease

https://t.co/gYDtiby6Ih

Follow DDW; Business insights for the global scientific community
#Parkinsons

[Yüksel Ürün @DrYukselUrun]

Can a virus help make immunotherapy work again?

FDA grants accelerated approval to oncolytic viral therapy Tudriqev + nivolumab after anti-PD-1 progression in advanced melanoma.

24% responded. Median response duration: 14.1 months. @US_FDA @OncoAlert @OpenMedicineHQ

[Sarah Clark @SarahClarkBDM]

🧪 A lablab bean–based chewing gum showed strong activity against detectable HPV and two bacteria associated with head and neck cancer in laboratory saliva tests. #healthcareIT #eHealth #healthcare #digitalhealth

[The Nobel Prize @NobelPrize]

���The new Nobel house will serve as an international symbol of knowledge – warm, welcoming and open to everyone. The efforts of the Nobel Prize laureates show how knowledge may change our world. What is impossible today may become possible tomorrow. Our goal is to make this power available to more people.”

- Hanna Stjärne, Executive Director of the Nobel Foundation 

We are building a home for the unique legacy of Alfred Nobel and hope you will join us for the journey. Our new home will be located in central Stockholm, Sweden – the birthplace of Alfred Nobel.

Follow along on our social channels as we move closer towards our dream of a new home opening in 2031. Stay tuned!

Learn more about our exciting plans: https://t.co/civ3kz5but

[Sarah Clark @SarahClarkBDM]

Immune and inflammatory markers and gut microbiome diversity, while the lack of change in PBMC epigenetic age highlights how complex biological aging is. #healthcareIT #eHealth #healthcare #digitalhealth

[IJGC @IJGConline]

✨ See you in 1 hour! #IJGCclub!
🗓️ Aug 6 | 7:00 am CDT / 2:00 pm CEST
📖 PARPi maintenance therapy with niraparib in patients with primary advanced or recurrent #endometrialcancer receiving dostarlimab plus chemotherapy with Matthew A. Powell

🔗 Don't miss this engaging discussion: https://t.co/U879Rhb83X

@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @ElePanizzolo @esragbilir @ChiaraAinio @alicezampolini @Chiara_4997 @Lawalqdus @kamillaldavid @Dra_AnaConde

[BioSpace @biospace]

Patients who receive an organ transplant must take difficult immuno-suppressive medicines for the rest of their lives. LifeMine Therapeutics wants to offer a safer alternative.

https://t.co/vaGsJeqyj3

[IEEE Engineering Medicine and Biology Society @IEEEembs]

#BioRob2026, which just wrapped up on Tuesday, brought together brilliant minds from #IEEE #EMBS & #IEEERAS for an unforgettable experience.

BioRob's keynotes, sessions, & workshops encompassed many areas of biorobotics & biomechatronics innovation.

[AI_4_Healthcare @AI_4_Healthcare]

This is Evidence of somthing BIG.
#AIinHealthcare

[BioSpace @biospace]

The additional cuts, which will primarily occur between 2027 and 2029, will cost some $6 billion as the pharma tries to ride out a post-COVID headache while facing stiff patent headwinds for major products like the blood thinner Eliquis.

https://t.co/RkmX3o5R2K

[Clinical Cancer Research @CCR_AACR]

Now online: Long-term results of multi-antigen stimulated cell therapy-I, alone or in combination with chemotherapy, as first-line maintenance therapy in advanced sarcoma: a multicenter, phase 1 trial https://t.co/SyYtSDuchs

[SABOURETCardiologist @SABOURETCardio]

During the #ESCCongress2026 you may join the #EAS booth and also join us on an early session on automated decision-making #CVR ☀️

[Raghu Venugopal MD @raghu_venugopal]

Self-serve medical care in Alberta for those who can afford it only makes shortages of medical radiation technologists worse. Ask any ER doctor - imaging is 100% reliant on technologists who are in short supply already. Alberta Conservatives choose dumb.
https://t.co/Y8FXH0BlVr

[IEEE Engineering Medicine and Biology Society @IEEEembs]

New in #IEEE PULSE!

Read Industry Corner: Live with Adaptyx Co-Founder & CEO @VijitSabnis by Chad Andresen and discover insights into the evolving landscape of digital health, biosensors, and personalized medicine.

🔗 https://t.co/VwCqiE2tBh

#MedTech #Bioengineering

[Erman Akkus @Erman_Akkus]

Clinical toxicity of ADCs and ICI–ADC combinations: mechanisms, patterns and management | Nature Reviews Clinical Oncology https://t.co/NKrvoxdxbx

[Mike Thompson, MD, PhD, FASCO @mtmdphd]

.@SWOG S2213 Ph3 RCT Dara-VC Induction Followed by ASCT or Dara-VCD Consolidation & Daratumumab Maintenance in Pts w/ Newly Diagnosed AL Amyloidosis [Activated: 12/1/23] https://t.co/OizUfJCc2c #mmsm #bmtsm

[Zain Khalpey, MD, PhD, FACS @ZainKhalpey]

A structured approach to chest X-ray interpretation improves accuracy and reduces missed findings.

Start with image quality, then evaluate the airways, lungs, heart, mediastinum, diaphragm, bones, and soft tissues.

@MattersoftheH14

#MedTwitter #Radiology #ChestXRay #MedicalEducation

[IASLC @IASLC]

A diagnosis may change your life. A patient’s voice can change the future.

Patient advocate @Yvonne_Diaz_ shares why advocacy, research, and equitable care matter for everyone affected by lung cancer.

Watch her World Lung Cancer Day message.

#WorldLungCancerDay #ConquerLungCancer